How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Sarcoma
Treatment Approaches Differ by Age Group in Extremity Soft Tissue Sarcoma
Young adults were more likely to receive chemotherapy.
Triplet Deemed New Standard Care for Relapsed or Refractory Rhabdomyosarcoma
Adding temozolomide to vincristine and irinotecan improved survival.
Avapritinib Does Not Improve PFS in Advanced Gastrointestinal Stromal Tumors
The VOYAGER study did not meet its primary endpoint.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
CMB305 Vaccine Demonstrates Activity But Doesn’t Improve Survival in Soft-Tissue Sarcomas
CMB305 increased antibody responses and NY-ESO-1-specific T-cell responses.
Study Reveals Genetic Features of Rhabdomyosarcoma That May Improve Risk Stratification
Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
Survival Rates Not Improving for AYAs With Sarcomas or Breast, Gynecologic Cancers
Survival improvements were noted in brain and nervous system cancers, colorectal cancers, and lung cancer.
Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...